One68 Global Capital’s Insmed INSM Stock Holding History

One68 Global Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,000	Closed	-$345K	–	111
2024 Q4	$345K	Buy	+5,000	New	+$360K	0.18%	65

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

One68 Global Capital's INSM Position: Q1 2025 in Review

One68 Global Capital sold out of Insmed (INSM) in Q1 2025, closing a stake of 5,000 shares — an estimated $345K sold.

One68 Global Capital first reported a position in INSM in Q4 2024 and held it in 1 quarter. The position peaked at $345K in Q4 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

One68 Global Capital reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
One68 Global Capital sold 5,000 Insmed shares in Q1 2025, an estimated $345K.
One68 Global Capital first reported a position in Insmed in Q4 2024 and held it in 1 quarter.
One68 Global Capital's Insmed position peaked at $345K in Q4 2024.
441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on One68 Global Capital's 13F filing for Q1 2025, filed 15 May 2025.